Solvay is to close a deal to sell its entire pharmaceutical business to Abbott for €5.2 bln in Q1-2010. The deal is subject to approval by the relevant competition authorities. Money raised by the sale will be invested in strategic projects in chemicals and plastics.
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}